The sales of Renin-Angiotensin System medicines in 2024 witnessed notable trends, with South Korea leading at $2.05 billion USD PPP, and Italy following at $1.91 billion USD PPP. The data indicates diverse market dynamics across countries. For example, Croatia and Canada showed moderate sales values of $0.7875 billion USD PPP and $0.7498 billion USD PPP respectively. Lower values were recorded in Portugal, Greece, and Belgium, reflecting smaller market sizes. Latin American and Scandinavian countries such as Chile and Sweden exhibited relatively low sales at $0.207 billion USD PPP and $0.099 billion USD PPP respectively, but with significant fluctuations. Costa Rica marked the smallest sales value at $0.0101 billion USD PPP.
The year-on-year variations for 2023 highlight positive trends in South Korea (6.03%) and Portugal (5.93%) whereas negative growth was observed in Canada (-2.97%), and Greece (-7.94%). Notable increases also appeared in Chile (7.89%) and Sweden (9.32%). On the other hand, Latvia and Costa Rica, despite having lower absolute sales, had divergent trends with Costa Rica seeing a substantial rise (7.61%) and Latvia a slight decrease (-3.07%).
Future trends to watch include potential growth in emerging markets and adjustments in larger markets due to healthcare policies and economic conditions. Advancements in medicine and treatment efficacy could also drive global sales dynamics, particularly in regions showing current high growth rates.
Top countries in Renin-Angiotensin System Medicine Sales by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 2,050 | 2023 | +3.77% | +6.03% | View data |
| 2 | 2 Italy | 1,910 | 2023 | +1.94% | +2.81% | View data |
| 3 | 3 Croatia | 787.5 | 2023 | +0.19% | +2.36% | View data |
| 4 | 4 Canada | 749.8 | 2023 | -7.26% | -2.97% | View data |
| 5 | 5 Australia | 532.7 | 2023 | +1.12% | +4.63% | View data |
| 6 | 6 Portugal | 458.5 | 2023 | +6.04% | +5.93% | View data |
| 7 | 7 Greece | 356 | 2023 | -6.54% | -7.94% | View data |
| 8 | 8 Belgium | 270 | 2023 | +1.09% | +4.03% | View data |
| 9 | 9 Czech Republic | 265.7 | 2023 | +1.22% | +2.56% | View data |
| 10 | 10 Chile | 207 | 2023 | +0.53% | +7.89% | View data |
